Search results: Sage Journals

Open accessReview articleFirst published 2015

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade

Peilin Zheng, Zhiguang Zhou

Biomarkers in Cancer

Open accessResearch articleFirst published 2020

Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials

Bin Zhao, Hong Zhao, Jiaxin Zhao

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published August, 2021

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Free accessLetterFirst published April, 2016

New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Cheng Chen, Jian-An Huang

European Journal of Inflammation

Free accessReview articleFirst published December, 2015

Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma

Matthew Weinstock, David McDermott

Therapeutic Advances in Urology

Free accessResearch articleFirst published May, 2018

Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer

Dan Tan, Li Sheng, Qing-Hua Yi

Cancer Biomarkers

Open accessResearch articleFirst published 2019

A Holistic Evaluation of Articles on PD-1 and PD-L1 Published Between 1975 and 2017: A Bibliometric Analysis

Yılmaz Baş, Engin Şenel

Cancer Informatics

Open accessResearch articleFirst published April, 2024

The regulation of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriasis itch and itch sensitization in mouse

Zhehao Xu, Yue Wang, Changcheng Jiang [...]

Molecular Pain

Free accessResearch articleFirst published July, 2021

PD-1,PD-L1,and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma

Valentina B. Stevenson, Samantha N. Perry, Michelle Todd [...]

Veterinary Pathology

Open accessResearch articleFirst published October, 2023

PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway

Shenghao Li, Muwei Dai, Fang Wang [...]

Natural Product Communications

Open accessReview articleFirst published 2015

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade

Peilin Zheng, Zhiguang Zhou

Biomarkers in Cancer

Open accessResearch articleFirst published 2020

Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials

Bin Zhao, Hong Zhao, Jiaxin Zhao

Therapeutic Advances in Medical Oncology

Restricted accessReview articleFirst published August, 2021

Potential and unsolved problems of anti-PD-1/PD-L1 therapy combined with radiotherapy

Yiyi Cao, Wenbo Li, ZhengJie Wang [...]

Tumori Journal

Free accessLetterFirst published April, 2016

New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Cheng Chen, Jian-An Huang

European Journal of Inflammation

Free accessReview articleFirst published December, 2015

Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma

Matthew Weinstock, David McDermott

Therapeutic Advances in Urology

Free accessResearch articleFirst published May, 2018

Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer

Dan Tan, Li Sheng, Qing-Hua Yi

Cancer Biomarkers

Open accessResearch articleFirst published 2019

A Holistic Evaluation of Articles on PD-1 and PD-L1 Published Between 1975 and 2017: A Bibliometric Analysis

Yılmaz Baş, Engin Şenel

Cancer Informatics

Open accessResearch articleFirst published April, 2024

The regulation of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriasis itch and itch sensitization in mouse

Zhehao Xu, Yue Wang, Changcheng Jiang [...]

Molecular Pain

Free accessResearch articleFirst published July, 2021

PD-1,PD-L1,and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma

Valentina B. Stevenson, Samantha N. Perry, Michelle Todd [...]

Veterinary Pathology

Open accessResearch articleFirst published October, 2023

PD-1/PD-L1 Interaction Upregulates YAP1 Expression in HepG2 Cells Through MAPK/ERK Pathway

Shenghao Li, Muwei Dai, Fang Wang [...]

Natural Product Communications